SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-069218
Filing Date
2019-03-08
Accepted
2019-03-08 16:45:34
Documents
5
Period of Report
2019-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d717351d8k.htm 8-K 49327
2 EX-4.1 d717351dex41.htm EX-4.1 1044316
3 EX-99.1 d717351dex991.htm EX-99.1 8797
4 EX-99.2 d717351dex992.htm EX-99.2 31022
5 GRAPHIC g717351dsp370.jpg GRAPHIC 7381
  Complete submission text file 0001193125-19-069218.txt   1145549
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 19669716
SIC: 2834 Pharmaceutical Preparations